GlassScriptPhysician profile
Philip W Tipton
NPI 1477940203
$18,752.32
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,238 · 2023: $869 · 2024: $476 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,175 · Consulting Fee: $2,450 · Food and Beverage: $1,697 · Travel and Lodging: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,175.00 |
| Consulting Fee | $2,450.00 |
| Food and Beverage | $1,697.31 |
| Travel and Lodging | $1,191.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,997.07 | 2022-2025 | Vercise, General - Dbs |
| Abbvie INC. | $6,187.41 | 2022-2025 | Duopa |
| Biogen, INC. | $133.54 | 2025 | Skyclarys |
| Medtronic, INC. | $98.22 | 2023 | Activa PC |
| Merz Pharmaceuticals, LLC | $75.90 | 2025 | Xeomin, Inbrija, Ampyra |
| Teva Pharmaceuticals USA, INC. | $58.10 | 2025 | Austedo Xr |
| Acadia Pharmaceuticals INC | $44.34 | 2022-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $43.16 | 2025 | Crexont |
| Averitas Pharma INC. | $35.76 | 2025 | Qutenza |
| Neurocrine Biosciences, INC. | $34.99 | 2025 | |
| Mdd US Operations, LLC | $23.35 | 2025 | |
| Ge Healthcare | $20.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Tipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.